Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0HWTRO)
| ADC Name |
SKB518
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
SKB518
Click to Show/Hide
|
|||||
| Organization |
Kelun Biotherapeutics (Originator)
|
|||||
| Drug Status |
Phase 2
|
|||||
| Antibody Name |
Anti-PTK7 antibody
|
Antibody Info | ||||
| Antigen Name |
Inactive tyrosine-protein kinase 7 (PTK7)
|
Antigen Info | ||||
| Payload Name |
KL610348
|
Payload Info | ||||
| Payload Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
Kthiol (pyrimidine-thiol) GGFG linker
|
Linker Info | ||||
| Conjugate Type |
Undisclosed
|
|||||
2027 Update
The disease landscape of This ADC
2027 Update
The clinical trial pipelines of This ADC
| Indication | Phase 1 | Phase 2 | Phase 3 | Approved | ||||
|---|---|---|---|---|---|---|---|---|
| Unspecific solid tumor |
1 Trials
|
1 Trials
|
||||||
| Lung cancer |
1 Trials
|
|||||||
| Peritoneal cancer |
1 Trials
|
|||||||
| Ovarian cancer |
1 Trials
|
|||||||
| Fallopian tube cancer |
1 Trials
|
|||||||
| Endometrial cancer |
1 Trials
|